[Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000526:Alprenolol / Q000494:pharmacology*; D000769:Anesthesia, Inhalation; D000818:Animals; D003374:Coumarins / Q000494:pharmacology; D004285:Dogs; D006221:Halothane; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D010096:Oxprenolol / Q000494:pharmacology*; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D003374:Coumarins; D011412:Propanolamines; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D006221:Halothane